Progressive infection in a subset of HIV-1-positive chimpanzees

Journal of Infectious Diseases

Volumn 182, Issue 4, 2000, Pages 1051-1062

  O'Neil, Shawn P ^a,b   Novembre, Francis J ^a,b   Hill, Anne Brodie ^a   Suwyn, Carolyn ^a   Hart, Clyde E ^c   Evans Strickfaden, Tammy ^c   Anderson, Daniel C ^a   DeRosayro, Juliette ^a   Herndon, James G ^a   Saucier, Michelle ^a   McClure, Harold M ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CAPSID PROTEIN; CD2 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS RNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CHIMPANZEE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMAL; ANTIGENS, CD29; ANTIGENS, DIFFERENTIATION; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HLA-DR ANTIGENS; HUMAN; LYMPH NODES; LYMPHOCYTE SUBSETS; MALE; NAD+ NUCLEOSIDASE; PAN TROGLODYTES; RECEPTORS, INTERLEUKIN-2; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; TIME FACTORS;

EID: 0033800721     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315823     Document Type: Article

References (116)

1. AIDS as a zoonosis: Scientific and public health implications
2. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes
3. Env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area
4. Multifactorial nature of human immunodeficiency virus disease: Implications for therapy
5. Host factors and the pathogenesis of HIV-induced disease
6. Toward an understanding of the correlates of protective immunity to HIV infection
7. The immunopathogenesis of human immunodeficiency virus infection
8. New concepts in the immunopathogenesis of HIV infection
9. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
10. Viral dynamics in human immunodeficiency virus type 1 infection
11. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection
12. Immunopathogenic mechanisms of HIV infection
13. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: Low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels
14. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection
15. Kinetics of immune functions and virus replication during HIV-1 infection
16. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors
17. The characterization of non-progressors: Long-term HIV-1 infection with stable CD4+ T-cell levels
18. Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort
19. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection: Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load
20. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
21. Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon
22. Isolation and characterization of a new chimpanzee lentivirus (simian immunodeficiency virus isolate cpz-ant) from a wild-captured chimpanzee
23. Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection
24. Sequence analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzee
25. Transmission of HTLV-III infection from human plasma to chimpanzees: An animal model for AIDS
26. Infection of chimpanzees with lymphadenopathy-associated virus
27. Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients
28. Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees
29. Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees
30. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: A potential model for acquired immunodeficiency syndrome
31. Nonhuman palmate models for AIDS
32. Rectal transmission of human immunodeficiency virus type 1 to chimpanzees
33. IgG response to human immunodeficiency virus in experimentally infected chimpanzees mimics the IgG response in humans
34. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction
35. Long-term observations of human immunodeficiency virus-infected chimpanzees
36. Virus-specific cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected chimpanzees
37. Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1
38. Antibodies are produced to the variable regions of the external envelope glycoprotein of human immunodeficiency virus type I in chimpanzees infected with the virus and baboons immunized with a candidate recombinant vaccine
39. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1
40. Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis
41. Programmed cell death and AIDS: Significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections
42. Programmed cell death in AIDS-related HIV and SIV infections
43. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype
44. Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants
45. AIDS: A disease of impaired Th-cell renewal?
46. HIV-infected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells
47. The relative resistance of HIV type 1-infected chimpanzees to AIDS correlates with the maintenance of follicular architecture and the absence of infiltration by CD8+ cytotoxic T lymphocytes
48. Quantitative, competitive PCR assay for HIV-1 using a microplate-based detection system
49. In vivo cell and tissue tropism of SIVsmmPBj14-bcl.3
50. Superinfection of a chimpanzee with a second strain of human immunodeficiency virus
51. Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees
52. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion
53. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
54. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: Markers with reciprocal predictive value over time after seroconversion
55. Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection: Swiss HIV Cohort Study Group
56. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children: National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
57. Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men
58. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements
59. Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline
60. Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism: French ALT Study Group
61. Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity
62. Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection
63. Lymphoid organs function as major reservoirs for human immunodeficiency virus
64. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
65. Quantitative image analysis of HIV-1 infection in lymphoid tissue
66. Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA
67. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study
68. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men
69. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: Which to choose and how to use
70. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1
71. Prolonged CD4+ lymphocytopenia and thrombocytopenia in a chimpanzee persistently infected with human immunodeficiency virus type 1
72. Patterns of T lymphocyte changes with human immunodeficiency virus infection: From seroconversion to the development of AIDS
73. Serial determinations of HIV-1 titers in HIV-infected homosexual men: Association of rising titers with CD4 T cell depletion and progression to AIDS
74. Phenotypic characterization of CD8+ T cell populations in HIV disease and in anti-HIV immunity
75. Long-term HIV-1 infection without immunologic progression
76. Subpopulations of CD4+ (T4+) cells in homosexual/bisexual men with persistent generalized lymphadenopathy
77. Lymphocyte immunophenotyping at the Centers for Disease Control: The program and special studies
78. Comparative analysis of CD4-4B4 and CD4-2H4 lymphocyte subpopulations in HIV negative homosexual, HIV seropositive and healthy subjects
79. Low relative frequencies of CD26(+) CD4(+) cells in long-term nonprogressing human immunodeficiency virus type 1-infected subjects
80. Activated naive and memory CD4+ and CD8+ subsets in different stages of HIV infection
81. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage
82. Markers of immune cell activation and disease progression: Cell activation in HIV disease
83. Three-color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection
84. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: Immunologic and virologic characteristics
85. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection
86. T cell activation and disease severity in HIV infection
87. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes
88. Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: Distinctive parameters of HIV-induced change
89. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: Staging and prognostic value
90. Immune changes in HIV-1 infection: Significant correlations and differences in serum markers and lymphoid phenotypic antigens
91. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: Results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study
92. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection
93. Lymphocyte subset analysis to predict progression to AIDS in a cohort of homosexual men in San Francisco
94. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression
95. Increases in soluble CD8 antigen in plasma, and CD8+ and CD8+CD38+ cells in human immunodeficiency virus type-1 infection
96. Predicting clinical progression or death in subjects with early-stage human immunodeficiency virus (HIV) infection: A comparative analysis of quantification of HIV RNA, soluble tumor necrosis factor type II receptors, neopterin, and beta2-microglobulin. Multicenter AIDS Cohort Study
97. Soluble receptors for tumour necrosis factor: A putative marker of disease progression in HIV infection
98. Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection
99. Serum beta 2-microglobulin level increases in HIV infection: Relation to seroconversion, CD4 T-cell fall and prognosis
100. Improvement of the predictive value of CD4+ lymphocyte count by beta 2- microglobulin, immunoglobulin A and erythrocyte sedimentation rate: The Multicentre Cohort Study Group
101. Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV infection
102. Predictors of progression in long-term nonprogressors: Australian Long-Term Nonprogressor Study Group
103. Immunohistochemical demonstration of p24 HTLV III major core protein in different cell types within lymph nodes from patients with lymphadenopathy syndrome (LAS)
104. HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy
105. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
106. Expression of RNA and antigens of human immunodeficiency virus type-1 (HIV-1) in lymph nodes from HIV-1 infected individuals
107. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS
108. Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections
109. Persistent and generalized lymphadenopathy: A lesion of follicular dendritic cells? An immunohistologic and ultrastructural study
110. Follicular dendritic cells and infection by human immunodeficiency virus type 1: A crucial target cell and virus reservoir
111. Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection
112. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: A review
113. Natural history of HIV infection
114. T helper cell activation and human retroviral pathogenesis
115. Molecular cloning and characterization of viruses isolated from chimpanzees with pathogenic human immunodeficiency virus type 1 infections